Intrinsic Value of S&P & Nasdaq Contact Us

Alterity Therapeutics Limited PRNAF OTC

Other OTC • Healthcare • Biotechnology • AU • USD

SharesGrow Score
48/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — PRNAF

Alterity Therapeutics Limited (PRNAF) has a market capitalization of $11.96M and trades at $0.00. The 52-week range is 0.0002-0.0139.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.6, Earnings Per Share (EPS) of $0.00, annual revenue of $5.44M.

The stock has a beta of -0.07, operates in the Healthcare sector.

Trading Data
Current Price$0.00
52-Week Range0.0002-0.0139
Volume10K
Avg Volume (30D)9.49K
Market Cap$11.96M
Beta (1Y)-0.07
Company
IPO Date2012-09-25
Employees10
CEODavid A. Stamler
CountryAU
ExchangeOther OTC
CurrencyUSD
ISINAU0000043945
Income (Latest Year)
Revenue$5.44M
Gross Profit$5.31M
EBITDA$-14.63M
Operating Income$-14.57M
Net Income$-12.15M
EPS$0.00
EPS Diluted$0.00
Shares Outstanding$6.4B
Balance Sheet (Latest Year)
Total Assets$46.03M
Current Assets$45.87M
Cash & ST Investments$40.66M
Total Liabilities$3.62M
Total Debt$155.46K
Net Debt$-33M
Total Equity$42.4M
Debt / Equity0.00
Valuation Ratios
P/E Ratio-0.6
P/S Ratio2.2
P/B Ratio0.28
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message